No Data
Express News | Aurinia Reports Presentation Of Two Studies At The Annual Congress Of Clinical Rheumatology
Aurinia Presents Data Reinforcing LUPKYNIS Safety and Efficacy for People With Lupus Nephritis at Congress of Clinical Rheumatology East 2024
A propensity analysis of ALMS, AURA-LV, and AURORA 1 suggested that initial therapy with LUPKYNIS plus standard of care reduced exposure to potential toxicities and demonstrated earlier reductions in proteinuria when
Express News | Shareholder Lucien Selce: Aurinia Should Immediately Link Management's Compensation to Fulfilling Quantitative Revenue Goals Set by Independent Board
Express News | Shareholder Lucien Selce: Aurinia Should Immediately Restructure Board and Reduce Its Size From Nine Directors to Five Directors
Express News | Shareholder Lucien Selce: Aurinia Board's Size Should Be Reduced to Ensure Efficiency and Cost-Effectiveness
Express News | Shareholder Lucien Selce: Believe Composition of Board, Excessive Number of Directors Sitting on It Holding Aurinia Back From Achieving Full Potential